Cohere Health’s Post

A new commentary published in Health Affairs recommends adopting a “race-aware,” as opposed to the current “race-based,” approach to the development and use of algorithms in healthcare to reduce disparities and advance a more equitable health system. The authors, including Arlene Bierman, M.D., M.S., AHRQ’s chief strategy officer, and Tina Hernandez-Boussard, Ph.D., M.P.H., M.S., a former member of AHRQ’s National Advisory Council, describe concerns about racial and ethnic biases built into algorithms that guide clinical decision-making. Algorithms that use race as a proxy for biological differences can lead to treatment patterns that are inappropriate, unjust, and harmful, they assert. The authors conclude that increasing the diversity of clinical trial populations, broadening the focus of precision medicine, improving education about the complex factors shaping health outcomes, and developing new guidelines and policies to enable culturally responsive care are important next steps. #HealthEquity https://bit.ly/3rDVRbQ

Understanding health equity as you develop your products and work through how they are implemented in health and care services is key to ensuring you aren’t inadvertently driving health inequity. Please join out medical director and health equity expert to get a better insight into this area at our upcoming webinar

A new commentary published in Health Affairs recommends adopting a “race-aware,” as opposed to the current “race-based,” approach to the development and use of algorithms in healthcare to reduce disparities and advance a more equitable health system. The authors, including Arlene Bierman, M.D., M.S., AHRQ’s chief strategy officer, and Tina Hernandez-Boussard, Ph.D., M.P.H., M.S., a former member of AHRQ’s National Advisory Council, describe concerns about racial and ethnic biases built into algorithms that guide clinical decision-making. Algorithms that use race as a proxy for biological differences can lead to treatment patterns that are inappropriate, unjust, and harmful, they assert. The authors conclude that increasing the diversity of clinical trial populations, broadening the focus of precision medicine, improving education about the complex factors shaping health outcomes, and developing new guidelines and policies to enable culturally responsive care are important next steps. #HealthEquity https://bit.ly/3rDVRbQ

A new commentary published in Health Affairs recommends adopting a “race-aware,” as opposed to the current “race-based,” approach to the development and use of algorithms in healthcare to reduce disparities and advance a more equitable health system. The authors, including Arlene Bierman, M.D., M.S., AHRQ’s chief strategy officer, and Tina Hernandez-Boussard, Ph.D., M.P.H., M.S., a former member of AHRQ’s National Advisory Council, describe concerns about racial and ethnic biases built into algorithms that guide clinical decision-making. Algorithms that use race as a proxy for biological differences can lead to treatment patterns that are inappropriate, unjust, and harmful, they assert. The authors conclude that increasing the diversity of clinical trial populations, broadening the focus of precision medicine, improving education about the complex factors shaping health outcomes, and developing new guidelines and policies to enable culturally responsive care are important next steps. #HealthEquity https://bit.ly/3rDVRbQ

A new commentary published in Health Affairs recommends adopting a “race-aware,” as opposed to the current “race-based,” approach to the development and use of algorithms in healthcare to reduce disparities and advance a more equitable health system. The authors, including Arlene Bierman, M.D., M.S., AHRQ’s chief strategy officer, and Tina Hernandez-Boussard, Ph.D., M.P.H., M.S., a former member of AHRQ’s National Advisory Council, describe concerns about racial and ethnic biases built into algorithms that guide clinical decision-making. Algorithms that use race as a proxy for biological differences can lead to treatment patterns that are inappropriate, unjust, and harmful, they assert. The authors conclude that increasing the diversity of clinical trial populations, broadening the focus of precision medicine, improving education about the complex factors shaping health outcomes, and developing new guidelines and policies to enable culturally responsive care are important next steps. #HealthEquity https://bit.ly/3rDVRbQ

A new commentary published in Health Affairs recommends adopting a “race-aware,” as opposed to the current “race-based,” approach to the development and use of algorithms in healthcare to reduce disparities and advance a more equitable health system. The authors, including Arlene Bierman, M.D., M.S., AHRQ’s chief strategy officer, and Tina Hernandez-Boussard, Ph.D., M.P.H., M.S., a former member of AHRQ’s National Advisory Council, describe concerns about racial and ethnic biases built into algorithms that guide clinical decision-making. Algorithms that use race as a proxy for biological differences can lead to treatment patterns that are inappropriate, unjust, and harmful, they assert. The authors conclude that increasing the diversity of clinical trial populations, broadening the focus of precision medicine, improving education about the complex factors shaping health outcomes, and developing new guidelines and policies to enable culturally responsive care are important next steps. #HealthEquity https://bit.ly/3rDVRbQ

Interesting read on how payers and health systems must find more productive ways of working together. It’s a priority strategy at Keck Medicine of USC. https://lnkd.in/evD4WWTu

Join our upcoming webinar focused on the vital issue of diversity in clinical trials. Learn how leveraging #RealWorldData can improve trial design, advance health equity, and generate strong #RealWorldEvidence. Don’t miss this chance to gain expert insights on enhancing diversity in clinical research! 🎟️ Register now: https://ow.ly/G20z50RH8w5 #ClinicalResearch #DiversityInTrials #HealthEquity

Come learn more about Diversity in Clinical Trials and #TriNetX tools to improve Trial Desing and Advancing Health Equity! Register now! #diversity #clinicaltrials

Join us at #arabhealth2024 to hear Islam ElTantawy speak on the pivotal role of Clinical Research Organizations in driving value via the transformative power of research to improve patient outcomes. M42 Health #ClinicalResearch #innovation